Research and Markets: New Frontiers in the US Clinical Chemistry and Immunodiagnostic Markets 2014: Business Challenges, Emerging Technologies, Competitive Landscape

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/7x2c6d/new_frontiers_in) has announced the addition of the "New Frontiers in the US Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape" report to their offering.

New Frontiers in the U.S. Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape; is Venture Planning Group's new study of the major business opportunities emerging in the U.S. clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the U.S. market; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

U.S. Market Overview

  • Estimates of facilities performing clinical chemistry and immunodiagnostic tests.
  • Test volume and sales projections.

Strategic Recommendations

  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.

Market Segmentation Analysis

  • Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.
  • Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by market segment:° Hospitals ° Commercial/Private Laboratories ° Physician Offices/Group Practices

The companies analyzed in the report include:

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio/Innogenetics
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

For more information visit http://www.researchandmarkets.com/research/7x2c6d/new_frontiers_in

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics